Evaluating the efficacy of omalizumab therapy in a group of adolescents with chronic urticaria in real clinical practice
Year: 2020
Type: article
Abstract: The treatment of chronic urticaria (CU) has some difficulties in pediatric. The main therapy of this disease in children and adolescents is the 2nd generation of H1-antihistamine medications. Patients with moderate and severe chronic urticaria, resistant to standard and increased doses of H1-antihistamines is used the therapy with a monoclonal antibody Omalizumab.
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,300
OpenAlex ID: W3088740468
